Prediction models of diabetes complications: a scoping review
暂无分享,去创建一个
Catherine H. Yu | H. Witteman | N. Ivers | B. Shah | R. Ndjaboué | Sharon E. Straus | S. Comeau | Charles Racine | Charlotte Rochefort-Brihay | G. Ngueta | D. Guay | O. Drescher | I. Farhat | Sasha Delorme | Sharon E Straus | S. Delorme | Imen Farhat
[1] V. Mohan,et al. Impact of age at type 2 diabetes mellitus diagnosis on mortality and vascular complications: systematic review and meta-analyses , 2020, Diabetologia.
[2] P. Kent,et al. A conceptual framework for prognostic research , 2020, BMC Medical Research Methodology.
[3] Catherine H. Yu,et al. Predictive models of diabetes complications: protocol for a scoping review , 2020, Systematic Reviews.
[4] V. Regitz-Zagrosek,et al. Impact of sex and gender on COVID-19 outcomes in Europe , 2020, Biology of Sex Differences.
[5] F. Schellevis,et al. Mismatch between self-perceived and calculated cardiometabolic disease risk among participants in a prevention program for cardiometabolic disease: a cross-sectional study , 2020, BMC Public Health.
[6] M. Pencina,et al. Prediction Models - Development, Evaluation, and Clinical Application. , 2020, The New England journal of medicine.
[7] H. Witteman,et al. Patients’ perspectives on how to improve diabetes care and self-management: qualitative study , 2020, BMJ Open.
[8] N. Wong,et al. Development of a Risk Score for Atrial Fibrillation in Adults With Diabetes Mellitus (from the ACCORD Study). , 2020, The American journal of cardiology.
[9] M. Kattan,et al. Predicting 10-Year Risk of End-Organ Complications of Type 2 Diabetes With and Without Metabolic Surgery: A Machine Learning Approach , 2020, Diabetes Care.
[10] I. Khalil,et al. Application of Machine Learning Models to Evaluate Hypoglycemia Risk in Type 2 Diabetes , 2020, Diabetes Therapy.
[11] Jun Lyu,et al. A potent risk model for predicting new-onset acute coronary syndrome in patients with type 2 diabetes mellitus in Northwest China , 2020, Acta Diabetologica.
[12] L. H. Nguyen,et al. Effects of Diabetic Complications on Health-Related Quality of Life Impairment in Vietnamese Patients with Type 2 Diabetes , 2020, Journal of diabetes research.
[13] Arnaub K Chatterjee,et al. A randomized study on the usefulness of an electronic outpatient hypoglycemia risk calculator for clinicians of patients with diabetes in a safety-net institution , 2020, Current medical research and opinion.
[14] M. Woodward,et al. Sex differences in the risk of vascular disease associated with diabetes , 2020, Biology of Sex Differences.
[15] Richard J Stevens,et al. Validation of clinical prediction models: what does the "calibration slope" really measure? , 2020, Journal of clinical epidemiology.
[16] B. Williams,et al. A risk prediction model for heart failure hospitalization in type 2 diabetes mellitus , 2019, Clinical cardiology.
[17] Oscar Barquero-Perez,et al. Pulse Wave Velocity and Machine Learning to Predict Cardiovascular Outcomes in Prediabetic and Diabetic Populations , 2019, Journal of Medical Systems.
[18] G. Fagherazzi,et al. Socioeconomic inequalities and type 2 diabetes complications: A systematic review. , 2019, Diabetes & metabolism.
[19] Yamei Cai,et al. Derivation and external validation of a risk prediction algorithm to estimate future risk of cardiovascular death among patients with type 2 diabetes and incident diabetic nephropathy: prospective cohort study , 2019, BMJ Open Diabetes Research & Care.
[20] V. Fuster,et al. Individualizing Revascularization Strategy for Diabetic Patients With Multivessel Coronary Disease. , 2019, Journal of the American College of Cardiology.
[21] Eli M Cahan,et al. Putting the data before the algorithm in big data addressing personalized healthcare , 2019, npj Digital Medicine.
[22] J. Duke,et al. Predictive modeling of hypoglycemia for clinical decision support in evaluating outpatients with diabetes mellitus , 2019, Current medical research and opinion.
[23] S. Kitto,et al. Protocol for a systematic scoping review of reasons given to justify the performance of randomised controlled trials , 2019, BMJ Open.
[24] B. Shah,et al. Derivation and Validation of a Risk-Prediction Tool for Hypoglycemia in Hospitalized Adults With Diabetes: The Hypoglycemia During Hospitalization (HyDHo) Score. , 2019, Canadian journal of diabetes.
[25] Lizheng Shi,et al. Correction to: Novel Risk Engine for Diabetes Progression and Mortality in USA: Building, Relating, Assessing, and Validating Outcomes (BRAVO) , 2019, PharmacoEconomics.
[26] Hetal S. Shah,et al. EstimatioN oF mORtality risk in type2 diabetiC patiEnts (ENFORCE): an inexpensive and parsimonious prediction model. , 2019, The Journal of clinical endocrinology and metabolism.
[27] B. J. Klevering,et al. Validation of a model for the prediction of retinopathy in persons with type 1 diabetes , 2019, British Journal of Ophthalmology.
[28] B. Davis,et al. Prediction of individual life-years gained without cardiovascular events from lipid, blood pressure, glucose, and aspirin treatment based on data of more than 500 000 patients with Type 2 diabetes mellitus. , 2019, European heart journal.
[29] C. Joseph,et al. Systematic scoping review protocol for clinical prediction rules (CPRs) in the management of patients with spinal cord injuries , 2019, BMJ Open.
[30] M. García-Fiñana,et al. Personalized risk‐based screening for diabetic retinopathy: A multivariate approach versus the use of stratification rules , 2018, Diabetes, obesity & metabolism.
[31] Catherine H. Yu,et al. Diabetes Canada 2018 clinical practice guidelines: Key messages for family physicians caring for patients living with type 2 diabetes. , 2019, Canadian family physician Medecin de famille canadien.
[32] G. Collins,et al. PROBAST: A Tool to Assess the Risk of Bias and Applicability of Prediction Model Studies , 2019, Annals of Internal Medicine.
[33] J. McGowan,et al. PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation , 2018, Annals of Internal Medicine.
[34] Kyungdo Han,et al. Development and validation of a risk prediction model for severe hypoglycemia in adult patients with type 2 diabetes: a nationwide population-based cohort study , 2018, Clinical epidemiology.
[35] G. Collins,et al. Fracture risk in type 2 diabetic patients: A clinical prediction tool based on a large population-based cohort , 2018, PloS one.
[36] J. Shaw,et al. Global trends in diabetes complications: a review of current evidence , 2018, Diabetologia.
[37] Björn Eliasson,et al. Risk Factors, Mortality, and Cardiovascular Outcomes in Patients with Type 2 Diabetes , 2018, The New England journal of medicine.
[38] F. Lo,et al. Nomogram for prediction of non-proliferative diabetic retinopathy in juvenile-onset type 1 diabetes: a cohort study in an Asian population , 2018, Scientific Reports.
[39] E. Seaquist,et al. Development of a model to predict 5-year risk of severe hypoglycemia in patients with type 2 diabetes , 2018, BMJ Open Diabetes Research & Care.
[40] Chia-Ing Li,et al. Development and validation of prediction models for the risks of diabetes-related hospitalization and in-hospital mortality in patients with type 2 diabetes. , 2018, Metabolism: clinical and experimental.
[41] F. Agakov,et al. Apolipoprotein CIII and N-terminal prohormone b-type natriuretic peptide as independent predictors for cardiovascular disease in type 2 diabetes. , 2018, Atherosclerosis.
[42] M. Kumar,et al. Diabetic Peripheral Neuropathy: Epidemiology, Diagnosis, and Pharmacotherapy. , 2018, Clinical therapeutics.
[43] Chia-Ing Li,et al. Establishment and validation of a prediction model for ischemic stroke risks in patients with type 2 diabetes. , 2018, Diabetes research and clinical practice.
[44] Riccardo Bellazzi,et al. Machine Learning Methods to Predict Diabetes Complications , 2018, Journal of diabetes science and technology.
[45] N. Ernstmann,et al. Information needs in people with diabetes mellitus: a systematic review , 2018, Systematic Reviews.
[46] E. Wan,et al. Development of a cardiovascular diseases risk prediction model and tools for Chinese patients with type 2 diabetes mellitus: A population‐based retrospective cohort study , 2018, Diabetes, obesity & metabolism.
[47] H. Witteman,et al. Diabetes‐related complications: Which research topics matter to diverse patients and caregivers? , 2017, Health Expectations.
[48] M. Coons,et al. Diabetes and Mental Health. , 2018, Canadian journal of diabetes.
[49] Catherine B. Chan,et al. Nutrition Therapy Diabetes Canada Clinical Practice Guidelines Expert Committee , 2018 .
[50] D. Grobbee,et al. Predictors of mortality in hospital survivors with type 2 diabetes mellitus and acute coronary syndromes , 2018, Diabetes & vascular disease research.
[51] S. Basu,et al. Validation of Risk Equations for Complications of Type 2 Diabetes (RECODe) Using Individual Participant Data From Diverse Longitudinal Cohorts in the U.S. , 2017, Diabetes Care.
[52] Donald R. Miller,et al. Development and Validation of a Tool to Identify Patients With Type 2 Diabetes at High Risk of Hypoglycemia-Related Emergency Department or Hospital Use , 2017, JAMA internal medicine.
[53] S. Basu,et al. Development and validation of Risk Equations for Complications Of type 2 Diabetes (RECODe) using individual participant data from randomised trials. , 2017, The lancet. Diabetes & endocrinology.
[54] Thomas Stoll,et al. Identification of Novel Circulating Biomarkers Predicting Rapid Decline in Renal Function in Type 2 Diabetes: The Fremantle Diabetes Study Phase II , 2017, Diabetes Care.
[55] E. Wan,et al. Prediction of new onset of end stage renal disease in Chinese patients with type 2 diabetes mellitus – a population-based retrospective cohort study , 2017, BMC Nephrology.
[56] J. Steiner,et al. Predicting the 6-month risk of severe hypoglycemia among adults with diabetes: Development and external validation of a prediction model. , 2017, Journal of diabetes and its complications.
[57] E. Wan,et al. Prediction of five-year all-cause mortality in Chinese patients with type 2 diabetes mellitus - A population-based retrospective cohort study. , 2017, Journal of diabetes and its complications.
[58] C. Yap,et al. HbA1c variability in type 2 diabetes is associated with the occurrence of new-onset albuminuria within three years. , 2017, Diabetes research and clinical practice.
[59] A. Rustgi,et al. A Clinical Prediction Model to Assess Risk for Pancreatic Cancer Among Patients With New-Onset Diabetes. , 2017, Gastroenterology.
[60] R. Hamman,et al. Association of Type 1 Diabetes vs Type 2 Diabetes Diagnosed During Childhood and Adolescence With Complications During Teenage Years and Young Adulthood , 2017, JAMA.
[61] Yu Qin,et al. Development and Validation of a Model for Predicting Diabetic Nephropathy in Chinese People. , 2017, Biomedical and environmental sciences : BES.
[62] R. Emsley,et al. Life Expectancy and Cause-Specific Mortality in Type 2 Diabetes: A Population-Based Cohort Study Quantifying Relationships in Ethnic Subgroups , 2016, Diabetes Care.
[63] N. Stone,et al. What to say and how to say it: effective communication for cardiovascular disease prevention , 2016, Current opinion in cardiology.
[64] J. Spertus,et al. Predicting Adverse Outcomes After Myocardial Infarction Among Patients With Diabetes Mellitus , 2016, Circulation. Cardiovascular quality and outcomes.
[65] M. Jørgensen,et al. Prediction of First Cardiovascular Disease Event in Type 1 Diabetes Mellitus: The Steno Type 1 Risk Engine , 2016, Circulation.
[66] J. Hippisley-Cox,et al. Development and validation of risk prediction equations to estimate future risk of heart failure in patients with diabetes: a prospective cohort study , 2015, BMJ Open.
[67] G. Heinze,et al. Risk Prediction for Early CKD in Type 2 Diabetes. , 2015, Clinical journal of the American Society of Nephrology : CJASN.
[68] C. Elley,et al. Development and validation of a predictive risk model for all-cause mortality in type 2 diabetes. , 2015, Diabetes research and clinical practice.
[69] L. Strycker,et al. Understanding the sources of diabetes distress in adults with type 1 diabetes. , 2015, Journal of diabetes and its complications.
[70] F. Agakov,et al. Protein biomarkers for the prediction of cardiovascular disease in type 2 diabetes , 2015, Diabetologia.
[71] D. Moher,et al. Scoping reviews: time for clarity in definition, methods, and reporting. , 2014, Journal of clinical epidemiology.
[72] G. Collins,et al. Critical Appraisal and Data Extraction for Systematic Reviews of Prediction Modelling Studies: The CHARMS Checklist , 2014, PLoS medicine.
[73] M. Budoff,et al. Development of a new diabetes risk prediction tool for incident coronary heart disease events: the Multi-Ethnic Study of Atherosclerosis and the Heinz Nixdorf Recall Study. , 2014, Atherosclerosis.
[74] I. Irigoien,et al. Development of a prediction model for fatal and non-fatal coronary heart disease and cardiovascular disease in patients with newly diagnosed type 2 diabetes mellitus: The Basque Country Prospective Complications and Mortality Study risk engine (BASCORE) , 2014, Diabetologia.
[75] M. Rewers,et al. Predicting major outcomes in type 1 diabetes: a model development and validation study , 2014, Diabetologia.
[76] L. Hooper,et al. Accuracy of prediction equations for serum osmolarity in frail older people with and without diabetes , 2014, The American journal of clinical nutrition.
[77] O. Dekkers,et al. Predicting Mortality in Patients with Diabetes Starting Dialysis , 2014, PloS one.
[78] W. Katon,et al. Risk score for prediction of 10 year dementia risk in individuals with type 2 diabetes: a cohort study. , 2013, The lancet. Diabetes & endocrinology.
[79] Sherita Hill Golden,et al. Race/Ethnic Difference in Diabetes and Diabetic Complications , 2013, Current Diabetes Reports.
[80] C. Elley,et al. Derivation and Validation of a Renal Risk Score for People With Type 2 Diabetes , 2013, Diabetes Care.
[81] M. Copetti,et al. Development and Validation of a Predicting Model of All-Cause Mortality in Patients With Type 2 Diabetes , 2013, Diabetes Care.
[82] V. Lagani,et al. A systematic review of predictive risk models for diabetes complications based on large scale clinical studies. , 2013, Journal of diabetes and its complications.
[83] K. Moons,et al. Diagnostic and prognostic prediction models , 2013, Journal of thrombosis and haemostasis : JTH.
[84] Atsushi Araki,et al. Predicting Macro- and Microvascular Complications in Type 2 Diabetes , 2013, Diabetes Care.
[85] Richard Cairns,et al. A clinical risk score for heart failure in patients with type 2 diabetes and macrovascular disease: an analysis of the PROactive study. , 2013, International journal of cardiology.
[86] D. Siscovick,et al. Prediction and classification of cardiovascular disease risk in older adults with diabetes , 2013, Diabetologia.
[87] P. Metcalf,et al. New Zealand Diabetes Cohort Study cardiovascular risk score for people with Type 2 diabetes: validation in the PREDICT cohort. , 2012, Journal of primary health care.
[88] S. Dutta,et al. Diabetic Complications: Current Challenges and Opportunities , 2012, Journal of Cardiovascular Translational Research.
[89] Carol M. Mangione,et al. Predictors of Mortality Over 8 Years in Type 2 Diabetic Patients , 2012, Diabetes Care.
[90] T. Wilt,et al. Predictors and Consequences of Severe Hypoglycemia in Adults with Diabetes - A Systematic Review of the Evidence , 2012 .
[91] J. Bergold,et al. Participatory Research Methods: A Methodological Approach in Motion , 2012 .
[92] St. Jean,et al. Information Behavior of People Diagnosed with a Chronic Serious Health Condition: A Longitudinal Study , 2012 .
[93] K G M Moons,et al. Prediction models for the risk of cardiovascular disease in patients with type 2 diabetes: a systematic review , 2011, Heart.
[94] Angelina Kouroubali,et al. Risk Assessment Models for Diabetes Complications: A Survey of Available Online Tools , 2011, MobiHealth.
[95] S. Gudbjörnsdottir,et al. A new model for 5‐year risk of cardiovascular disease in Type 1 diabetes; from the Swedish National Diabetes Register (NDR) , 2011, Diabetic medicine : a journal of the British Diabetic Association.
[96] N. Jewell,et al. Prediction, by retinal location, of the onset of diabetic edema in patients with nonproliferative diabetic retinopathy. , 2011, Investigative ophthalmology & visual science.
[97] S. Gudbjörnsdottir,et al. A new model for 5-year risk of cardiovascular disease in type 2 diabetes, from the Swedish National Diabetes Register (NDR). , 2011, Diabetes research and clinical practice.
[98] G. Zarini,et al. The Healthy Eating Index and the Alternate Healthy Eating Index as predictors of 10-year CHD risk in Cuban Americans with and without type 2 diabetes , 2011, Public Health Nutrition.
[99] S. Haneuse,et al. Designs for the Combination of Group- and Individual-level Data , 2011, Epidemiology.
[100] J. Gross,et al. Diabetic Retinopathy Predicts All-Cause Mortality and Cardiovascular Events in Both Type 1 and 2 Diabetes , 2011, Diabetes Care.
[101] Mark Woodward,et al. Contemporary model for cardiovascular risk prediction in people with type 2 diabetes , 2011, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.
[102] N. Jewell,et al. Multifocal electroretinograms predict onset of diabetic retinopathy in adult patients with diabetes. , 2011, Investigative Ophthalmology and Visual Science.
[103] W. Brown. Framingham Heart Study. , 2011, Journal of clinical lipidology.
[104] N. Chaturvedi,et al. Development of a coronary heart disease risk prediction model for type 1 diabetes: the Pittsburgh CHD in Type 1 Diabetes Risk Model. , 2010, Diabetes research and clinical practice.
[105] M W Knuiman,et al. An Australian cardiovascular risk equation for type 2 diabetes: the Fremantle Diabetes Study , 2010, Internal medicine journal.
[106] C. Raina Elley,et al. Derivation and Validation of a New Cardiovascular Risk Score for People With Type 2 Diabetes , 2010, Diabetes Care.
[107] N. Obuchowski,et al. Assessing the Performance of Prediction Models: A Framework for Traditional and Novel Measures , 2010, Epidemiology.
[108] M. Rewers,et al. Progression to microalbuminuria in type 1 diabetes: development and validation of a prediction rule , 2009, Diabetologia.
[109] R. Mccallum,et al. Comparison of the Framingham and United Kingdom Prospective Diabetes Study cardiovascular risk equations in Australian patients with type 2 diabetes from the Fremantle Diabetes Study , 2009, The Medical journal of Australia.
[110] Ruth Williams. Patients' perspectives. , 2009, Nursing management.
[111] Björn Eliasson,et al. Risk Prediction of Cardiovascular Disease in Type 2 Diabetes , 2008, Diabetes Care.
[112] Xilin Yang,et al. Predicting values of lipids and white blood cell count for all-site cancer in type 2 diabetes. , 2008, Endocrine-related cancer.
[113] Xilin Yang,et al. Development and validation of a risk score for hospitalization for heart failure in patients with Type 2 Diabetes Mellitus , 2008, Cardiovascular diabetology.
[114] Xilin Yang,et al. Development and validation of an all-cause mortality risk score in type 2 diabetes. , 2008, Archives of internal medicine.
[115] Xilin Yang,et al. Development and validation of a total coronary heart disease risk score in type 2 diabetes mellitus. , 2008, The American journal of cardiology.
[116] Jan P Vandenbroucke,et al. Observational Research, Randomised Trials, and Two Views of Medical Science , 2008, PLoS medicine.
[117] A. Kong,et al. Development and Validation of an All-Cause Mortality Risk Score in Type 2 Diabetes The Hong Kong Diabetes Registry , 2008 .
[118] Vivian Wong,et al. Development and Validation of Stroke Risk Equation for Hong Kong Chinese Patients With Type 2 Diabetes , 2007, Diabetes Care.
[119] A. Kong,et al. End-stage renal disease risk equations for Hong Kong Chinese patients with type 2 diabetes: Hong Kong Diabetes Registry , 2006, Diabetologia.
[120] Gretchen A. Piatt,et al. Deficiencies of Cardiovascular Risk Prediction Models for Type 1 Diabetes A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances. , 2006, Diabetes Care.
[121] Ying Zhang,et al. Prediction of Coronary Heart Disease in a Population With High Prevalence of Diabetes and Albuminuria: The Strong Heart Study , 2006, Circulation.
[122] V. Montori,et al. A pen-and-paper coronary risk estimator for office use with patients with type 2 diabetes. , 2006, Mayo Clinic proceedings.
[123] K. Donaghue,et al. Complications of diabetes mellitus in childhood. , 2005, Pediatric clinics of North America.
[124] A. Boulton,et al. The global burden of diabetic foot disease , 2005, The Lancet.
[125] C. Byrne,et al. Prognostic value of the Framingham cardiovascular risk equation and the UKPDS risk engine for coronary heart disease in newly diagnosed Type 2 diabetes: results from a United Kingdom study , 2005, Diabetic medicine : a journal of the British Diabetic Association.
[126] H. Arksey,et al. Scoping studies: towards a methodological framework , 2005 .
[127] R. Stevens,et al. UKPDS 60: Risk of Stroke in Type 2 Diabetes Estimated by the UK Prospective Diabetes Study Risk Engine , 2002, Stroke.
[128] R. Holman,et al. The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56). , 2001, Clinical science.
[129] A. Karter,et al. Developing a prediction rule from automated clinical databases to identify high-risk patients in a large population with diabetes. , 2001, Diabetes care.
[130] W. Spitzer. Meta-meta-analysis: unanswered questions about aggregating data. , 1991, Journal of clinical epidemiology.